Literature DB >> 26476225

Etiology and Pathogenesis of Psoriasis.

Wolf-Henning Boehncke1.   

Abstract

Psoriasis is a common, chronic inflammatory skin disease most often appearing in the form of well-demarcated, scaly plaques. These lesions highlight the fundamental processes underlying its pathogenesis, namely, inflammation and epidermal hyperproliferation. Both phenomena are considered consequences of an intimate interplay between the innate and the adaptive immune system. This concept is supported by results of genetic studies, pointing toward the signaling pathways of nuclear factor-κB, interferon-γ, and interleukin (IL)-23 as well as antigen presentation as central axes of the psoriatic inflammation. Efficacy of biologics targeting tumor necrosis factor-α, IL-23, or IL-17 provides further evidence in favor of this model.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dendritic cells; Etiology; Genome-wide association study; IL-17; Keratinocytes; Pathogenesis; Psoriasis; T lymphocytes

Mesh:

Substances:

Year:  2015        PMID: 26476225     DOI: 10.1016/j.rdc.2015.07.013

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  41 in total

1.  Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis.

Authors:  Padmini Iriventi; N Vishal Gupta; Riyaz Ali M Osmani; V Balamuralidhara
Journal:  Daru       Date:  2020-05-29       Impact factor: 3.117

2.  Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis.

Authors:  M De Andrea; M De Santis; V Caneparo; E Generali; S Sirotti; N Isailovic; G M Guidelli; A Ceribelli; M Fabbroni; A Simpatico; L Cantarini; P Gisondi; L Idolazzi; M Gariglio; C Selmi
Journal:  Clin Exp Immunol       Date:  2019-10-15       Impact factor: 4.330

3.  Identification of proresolving and inflammatory lipid mediators in human psoriasis.

Authors:  Alexander V Sorokin; Paul C Norris; Justin T English; Amit K Dey; Abhishek Chaturvedi; Yvonne Baumer; Joanna Silverman; Martin P Playford; Charles N Serhan; Nehal N Mehta
Journal:  J Clin Lipidol       Date:  2018-04-06       Impact factor: 4.766

4.  Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study.

Authors:  Alanna C Bridgman; Abrar A Qureshi; Tricia Li; Fred K Tabung; Eunyoung Cho; Aaron M Drucker
Journal:  J Am Acad Dermatol       Date:  2019-02-21       Impact factor: 11.527

5.  Methotrexate Mechanism of Action in Plaque Psoriasis: Something New in the Old View.

Authors:  Fatma Mohamed El-Esawy; Inas A Ahmed; Asmaa Adel El-Fallah; Rehab Mohammed Salem
Journal:  J Clin Aesthet Dermatol       Date:  2022-08

Review 6.  Progranulin: A key player in autoimmune diseases.

Authors:  Jinlong Jian; Guangfei Li; Aubryanna Hettinghouse; Chuanju Liu
Journal:  Cytokine       Date:  2016-08-12       Impact factor: 3.861

7.  Recruitment and Retention in a Randomized Control Trial of Increased Dietary Protein-to-Carbohydrate Ratios in Patients with Psoriasis.

Authors:  Anders Nikolai Ørsted Schultz; Peter Jensen; John Robert Zibert; Maria Falck Stigsby; Martin Malmstedt-Miller; Elisabeth B M Petersen; Lone Skov; Bjarne Stigsby
Journal:  Acta Derm Venereol       Date:  2020-01-07       Impact factor: 3.875

8.  Therapy of psoriasis with narrowband ultraviolet-B light influences plasma concentrations of MMP-2 and TIMP-2 in patients.

Authors:  Edyta Katarzyna Głażewska; Marek Niczyporuk; Sławomir Ławicki; Maciej Szmitkowski; Monika Zajkowska; Grażyna Ewa Będkowska; Andrzej Przylipiak
Journal:  Ther Clin Risk Manag       Date:  2016-10-21       Impact factor: 2.423

9.  Seborrheic Dermatitis and Dandruff: A Comprehensive Review.

Authors:  Luis J Borda; Tongyu C Wikramanayake
Journal:  J Clin Investig Dermatol       Date:  2015-12-15

Review 10.  Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis.

Authors:  V Di Lernia; F Bardazzi
Journal:  Drug Des Devel Ther       Date:  2016-01-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.